S&P 500   3,256.22 (-1.63%)
DOW   26,331.43 (-1.23%)
QQQ   268.46 (-2.87%)
AAPL   108.94 (-5.53%)
MSFT   200.39 (-2.12%)
FB   262.20 (-6.63%)
GOOGL   1,615.08 (+3.74%)
AMZN   3,058.60 (-4.75%)
TSLA   385.53 (-6.16%)
NVDA   496.44 (-4.71%)
BABA   301.88 (-3.42%)
CGC   18.29 (-2.61%)
GE   7.37 (+0.00%)
MU   49.62 (-1.70%)
AMD   74.84 (-4.08%)
T   26.87 (+0.41%)
F   7.69 (-2.66%)
ACB   3.93 (-3.91%)
GILD   57.46 (-1.83%)
NIO   30.55 (-4.50%)
NFLX   476.02 (-5.59%)
BA   143.13 (-3.48%)
DIS   119.77 (-1.46%)
S&P 500   3,256.22 (-1.63%)
DOW   26,331.43 (-1.23%)
QQQ   268.46 (-2.87%)
AAPL   108.94 (-5.53%)
MSFT   200.39 (-2.12%)
FB   262.20 (-6.63%)
GOOGL   1,615.08 (+3.74%)
AMZN   3,058.60 (-4.75%)
TSLA   385.53 (-6.16%)
NVDA   496.44 (-4.71%)
BABA   301.88 (-3.42%)
CGC   18.29 (-2.61%)
GE   7.37 (+0.00%)
MU   49.62 (-1.70%)
AMD   74.84 (-4.08%)
T   26.87 (+0.41%)
F   7.69 (-2.66%)
ACB   3.93 (-3.91%)
GILD   57.46 (-1.83%)
NIO   30.55 (-4.50%)
NFLX   476.02 (-5.59%)
BA   143.13 (-3.48%)
DIS   119.77 (-1.46%)
S&P 500   3,256.22 (-1.63%)
DOW   26,331.43 (-1.23%)
QQQ   268.46 (-2.87%)
AAPL   108.94 (-5.53%)
MSFT   200.39 (-2.12%)
FB   262.20 (-6.63%)
GOOGL   1,615.08 (+3.74%)
AMZN   3,058.60 (-4.75%)
TSLA   385.53 (-6.16%)
NVDA   496.44 (-4.71%)
BABA   301.88 (-3.42%)
CGC   18.29 (-2.61%)
GE   7.37 (+0.00%)
MU   49.62 (-1.70%)
AMD   74.84 (-4.08%)
T   26.87 (+0.41%)
F   7.69 (-2.66%)
ACB   3.93 (-3.91%)
GILD   57.46 (-1.83%)
NIO   30.55 (-4.50%)
NFLX   476.02 (-5.59%)
BA   143.13 (-3.48%)
DIS   119.77 (-1.46%)
S&P 500   3,256.22 (-1.63%)
DOW   26,331.43 (-1.23%)
QQQ   268.46 (-2.87%)
AAPL   108.94 (-5.53%)
MSFT   200.39 (-2.12%)
FB   262.20 (-6.63%)
GOOGL   1,615.08 (+3.74%)
AMZN   3,058.60 (-4.75%)
TSLA   385.53 (-6.16%)
NVDA   496.44 (-4.71%)
BABA   301.88 (-3.42%)
CGC   18.29 (-2.61%)
GE   7.37 (+0.00%)
MU   49.62 (-1.70%)
AMD   74.84 (-4.08%)
T   26.87 (+0.41%)
F   7.69 (-2.66%)
ACB   3.93 (-3.91%)
GILD   57.46 (-1.83%)
NIO   30.55 (-4.50%)
NFLX   476.02 (-5.59%)
BA   143.13 (-3.48%)
DIS   119.77 (-1.46%)
Log in
OTCMKTS:RHHBY

Roche Stock Forecast, Price & News

$40.20
+0.11 (+0.27 %)
(As of 10/29/2020 12:00 AM ET)
Add
Compare
Today's Range
$39.89
Now: $40.20▼
$40.50
50-Day Range
$40.09
MA: $43.72▼
$46.84
52-Week Range
$35.04
Now: $40.20▼
$47.15
Volume1.27 million shs
Average Volume1.82 million shs
Market Capitalization$275.31 billion
P/E Ratio15.83
Dividend Yield1.80%
Beta0.32
Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anemia, cancer, cardiovascular, central nervous system, dermatology, hepatitis B and C, HIV/AIDS, inflammatory and autoimmune, intensive care medicine, leukemia, lymphoma, metabolic disorders, ophthalmology, respiratory disorders, rheumatoid arthritis, skin cancer, and transplantation. The company also offers in vitro diagnostics solutions for indications, such as cardiology, hematology, blood donor screening, coagulation, infectious disease, gynecology, oncology, and women's health. In addition, it supplies diagnostic instruments, reagents, consumables, and test kits for use in the diverse research market. Further, the company discovers, develops, and delivers gene therapies. Roche Holding AG has collaboration with Gilead Sciences, Inc. for COVID-19. Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.
Read More
Roche logo

Beat the Market (BTM) Rank™

Analyst Opinion: 2.4Community Rank: 2.4Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.83 out of 5 stars

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:RHHBY
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.roche.com
Phone41-61-688-1111
Employees97,735

Debt

Debt-to-Equity Ratio0.36
Current Ratio1.23
Quick Ratio0.93

Price-To-Earnings

Trailing P/E Ratio15.83
Forward P/E Ratio15.11
P/E Growth3.01

Sales & Book Value

Annual Sales$61.87 billion
Price / Sales4.45
Cash Flow$3.03 per share
Price / Cash Flow13.26
Book Value$5.27 per share
Price / Book7.63

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares6,848,490,000
Market Cap$275.31 billion
Next Earnings DateN/A
OptionableNot Optionable
$40.20
+0.11 (+0.27 %)
(As of 10/29/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RHHBY News and Ratings via Email

Sign-up to receive the latest news and ratings for RHHBY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Roche (OTCMKTS:RHHBY) Frequently Asked Questions

How has Roche's stock been impacted by Coronavirus (COVID-19)?

Roche's stock was trading at $40.91 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, RHHBY shares have decreased by 1.7% and is now trading at $40.20.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Roche?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Roche in the last year. There are currently 1 sell rating, 2 hold ratings, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Roche.

What price target have analysts set for RHHBY?

14 brokerages have issued 1-year target prices for Roche's shares. Their forecasts range from $48.00 to $48.00. On average, they anticipate Roche's share price to reach $48.00 in the next twelve months. This suggests a possible upside of 19.4% from the stock's current price.
View analysts' price targets for Roche.

Are investors shorting Roche?

Roche saw a decrease in short interest in October. As of October 15th, there was short interest totaling 295,800 shares, a decrease of 20.0% from the September 30th total of 369,900 shares. Based on an average trading volume of 1,257,300 shares, the days-to-cover ratio is presently 0.2 days.
View Roche's Short Interest.

Who are some of Roche's key competitors?

Some companies that are related to Roche include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Novartis (NVS), Novo Nordisk A/S (NVO), AbbVie (ABBV), AstraZeneca (AZN), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), Eli Lilly and (LLY), Sanofi (SNY), Sanofi (SNY), Commonwealth Bank of Australia (CSLLY) and GlaxoSmithKline (GSK).
View all competitors.

Who are Roche's key executives?

Roche's management team includes the following people:
  • Dr. Severin Schwan, CEO & Exec. Director (Age 53)
  • Dr. Alan Hippe, Chief Financial & IT Officer (Age 53)
  • Dr. Karl Mahler, Head of Investor Relations
  • Dr. Urs Jaisli, Chief Compliance Officer (Age 64)
  • Ms. Claudia Böckstiegel, Gen. Counsel (Age 56)
  • Ms. Cristina A. Wilbur, Chief People Officer (Age 53)
  • Mr. Nicolas Dunant, Head of Group Media Relations
  • Ehab Yousef, Head of Middle East Sub-Region 1
  • Mr. Boris L. Zaitra, Head of Group M&A (Age 48)
  • Lance Duan, Managing Director

What is Roche's stock symbol?

Roche trades on the OTCMKTS under the ticker symbol "RHHBY."

Who are Roche's major shareholders?

Roche's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (0.01%), Ferguson Wellman Capital Management Inc. (0.01%), Osher Van de Voorde Investment Management (0.00%), LSV Asset Management (0.00%), Park National Corp OH (0.00%) and Anderson Hoagland & Co. (0.00%).

Which major investors are selling Roche stock?

RHHBY stock was sold by a variety of institutional investors in the last quarter, including LSV Asset Management, New England Research & Management Inc., Wendell David Associates Inc., Anderson Hoagland & Co., Bath Savings Trust Co, Confluence Investment Management LLC, Wallington Asset Management LLC, and Private Trust Co. NA.

Which major investors are buying Roche stock?

RHHBY stock was purchased by a variety of institutional investors in the last quarter, including Pacer Advisors Inc., Riverbridge Partners LLC, Ferguson Wellman Capital Management Inc., Osher Van de Voorde Investment Management, Fulton Bank N. A., Moloney Securities Asset Management LLC, Park National Corp OH, and Vigilant Capital Management LLC.

How do I buy shares of Roche?

Shares of RHHBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Roche's stock price today?

One share of RHHBY stock can currently be purchased for approximately $40.20.

How big of a company is Roche?

Roche has a market capitalization of $275.31 billion and generates $61.87 billion in revenue each year. The company earns $13.58 billion in net income (profit) each year or $2.54 on an earnings per share basis. Roche employs 97,735 workers across the globe.

What is Roche's official website?

The official website for Roche is www.roche.com.

How can I contact Roche?

Roche's mailing address is GRENZACHERSTRASSE 124, BASEL V8, CH-4070. The company can be reached via phone at 41-61-688-1111 or via email at [email protected]

This page was last updated on 10/30/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.